Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BASKING RIDGE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
-
BASKING RIDGE, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a development...
-
BASKING RIDGE, N.J., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
-
BASKING RIDGE, N.J., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a development...
-
BASKING RIDGE, N.J., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius”), a company combining a leading cell therapy service provider with a therapeutics...
-
BASKING RIDGE, N.J., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a cell therapy company combining an industry-leading external development and manufacturing provider...
-
BASKING RIDGE, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a company combining a leading cell therapy service provider with a development pipeline including a...
-
BASKING RIDGE, N.J., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. ("Caladrius" or the "Company") (NASDAQ:CLBS), a cell therapy company combining an industry-leading external...
-
BASKING RIDGE, N.J., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. ("Caladrius" or the "Company") (NASDAQ:CLBS), a cell therapy company combining an industry-leading external...
-
BASKING RIDGE, N.J., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a company combining a leading cell therapy service provider with a development pipeline including a...